Montelukast Recall

Date: August 31, 2018 To: Health Plan of San Joaquin (HPSJ) Pharmacies and PCPs From: HPSJ Pharmacy Department Subject: Montelukast Recall Business: Medi-Cal Montelukast Recall We are sending this alert because your patients may have filled a prescription for Montelukast Sodium 10mg Tablets. The product is labeled as Montelukast Sodium Tablets USP 10mg, but may […]

Read more

Hydrochlorothiazide Recall

Date: August 30, 2018 To: Health Plan of San Joaquin (HPSJ) Pharmacies and PCPs From: HPSJ Pharmacy Department Subject: Hydrochlorothiazide Recall Business: Medi-Cal Hydrochlorothiazide Recall We are sending this alert because your patients may have filled a prescription for Hydrochlorothiazide 12.5mg Tablet. The product is labeled as Hydrochlorothiazide Tablet USP 12.5mg, but may contain Spironolactone […]

Read more

Health Plan of San Joaquin (HPSJ) announces 2018 Health Careers Scholarships (HCS) and Mentors

Health Plan of San Joaquin (HPSJ) announces 2018 Health Careers Scholarships (HCS) and Mentors – HPSJ will increase scholarship support level for next year’s HCS scholars (French Camp, CA) – Health Plan of San Joaquin continues to encourage future Central Valley doctors, nurses and pharmacists. With its Health Careers Scholarships (HCS) program, HPSJ this year supports up […]

Read more

Advance Notice of Possible Site Reviews – 2018 DHCS Audit

Date: August 13, 2018 To: Health Plan of San Joaquin (HPSJ Primary Care Providers (PCP) and Specialists From: Compliance Department Subject: Advance Notice of Possible Site Reviews – 2018 DHCS Audit Business: Medi-Cal California’s Department of Health Care Services (DHCS) has scheduled a routine annual medical audit of Health Plan of San Joaquin (HPSJ). The […]

Read more

Adverse Effects from Fluoroquinolone Antibiotics

Date: August 9, 2018 To: HPSJ Primary Care Providers, Specialists, and Pharmacies From: Health Plan of San Joaquin Pharmacy Department Subject: Adverse Effects from Fluoroquinolone Antibiotics Business: Medi-Cal The Department of Health Care Services (DHCS) wants all providers to be aware of the FDA announcement for potential risks of fluoroquinolone use. The following safety warnings […]

Read more

NCQA Reaccreditation for Health Plan of San Joaquin

Date: August 6, 2018 To: HPSJ Providers From: Health Plan of San Joaquin Subject: NCQA Reaccreditation for Health Plan of San Joaquin Business: Medi-Cal The National Committee for Quality Assurance (NCQA) has awarded Health Plan of San Joaquin its three-year re-accreditation in the category of Medicaid HMO. NCQA is one of the most comprehensive evaluations […]

Read more

NCQA reaccreditation for Health Plan of San Joaquin (HPSJ)

(French Camp, CA) – The National Committee for Quality Assurance (NCQA) has awarded Health Plan of San Joaquin its three-year reaccreditation in the category of Medicaid HMO. NCQA is one of the most comprehensive evaluations in the health insurance industry. HPSJ Chief Medical Officer Lakshmi Dhanvanthari, MD, said: “Health Plans accredited by NCQA demonstrate their […]

Read more

ProDUR Update: Additive Toxicity Alert Now Focused Only On CNS Depressants

Learning Objectives: Describe the drug safety communications by the U.S. Food and Drug Administration (FDA) regarding the combined use of opioid medicines with benzodiazepines or other drugs that depress the central nervous system (CNS). Review the changes to the additive toxicity (AT) prospective drug utilization review (DUR) alert. Summarize best practices for responsible prescribing of […]

Read more

1 … 69 70 71 72 73 … 104
top